These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 313526)

  • 1. Lymphomas with cytotoxic activity.
    Chang TW; Eisen HN
    Nature; 1979 Aug; 280(5721):406-8. PubMed ID: 313526
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 3. Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity.
    Bertoglio J; Gerlier D; Gerard JP
    Clin Exp Immunol; 1981 Apr; 44(1):137-44. PubMed ID: 6973429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression and restoration of cytotoxic T-cell activity during chemotherapy of a mouse T-cell lymphoma and a macrophage tumor.
    Tarnowski GS; Faanes RB; Ralph P; Williams N
    Cancer Res; 1978 Dec; 38(12):4540-5. PubMed ID: 309790
    [No Abstract]   [Full Text] [Related]  

  • 6. Blastogenesis & DNA synthesis in concanavalin A--driven regeneration of cytotoxic response in memory T cells.
    Chakravarty AK
    Indian J Exp Biol; 1978 Feb; 16(2):148-52. PubMed ID: 308043
    [No Abstract]   [Full Text] [Related]  

  • 7. Rabbit anti-EL4 serum. A reagent with specificity for a population of murine suppressor cells.
    Al-Sakkaf L; Cooke A; Hutchings P; Jones B
    Immunology; 1979 Oct; 38(2):375-83. PubMed ID: 159864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytotoxic T lymphocyte activity by concanavalin A.
    Sitkovsky MV; Pasternack MS; Eisen HN
    J Immunol; 1982 Oct; 129(4):1372-6. PubMed ID: 6980931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity.
    Conzelmann A; Corthésy P; Cianfriglia M; Silva A; Nabholz M
    Nature; 1982 Jul; 298(5870):170-2. PubMed ID: 6979720
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of T cell effector function by concanavalin A.
    Miltenberg AM; Meijer-Paape ME; Daha MR; Paul LC
    Transplant Proc; 1988 Apr; 20(2):293. PubMed ID: 3259033
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of cytotoxic T-lymphocytes in tumour bearing animals: procedures to isolate highly active populations.
    Vasudevan DM; Vijayakumar T
    Indian J Cancer; 1977 Dec; 14(4):354-60. PubMed ID: 306380
    [No Abstract]   [Full Text] [Related]  

  • 12. Clonal specificity of concanavalin A-induced cytotoxic T lymphocytes.
    Larsson EL; Beretta A; Ermonval M
    Eur J Immunol; 1985 Apr; 15(4):400-3. PubMed ID: 3872802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage tumor cells can help to cure murine lymphoma.
    Van Loveren H; De Groot JW; Den Otter W
    Proc Soc Exp Biol Med; 1981 Jun; 167(2):207-11. PubMed ID: 6972046
    [No Abstract]   [Full Text] [Related]  

  • 15. Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.
    Bonavida B
    J Exp Med; 1977 Feb; 145(2):293-301. PubMed ID: 299880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of cells and factors participating in the concanavalin A-dependent activation of T lymphocytes with cytotoxic potential.
    Larsson EL; Gullberg M; Coutinho A
    Immunobiology; 1982 Mar; 161(1-2):5-20. PubMed ID: 6807829
    [No Abstract]   [Full Text] [Related]  

  • 17. CT hybridomas: tumor cells capable of lysing virally infected target cells.
    Whitaker RB; Kauffman RS; Che M; Finberg R
    J Immunol; 1982 Aug; 129(2):900-3. PubMed ID: 6282974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the recognition of target cells sensitive to or resistant to cytolysis by activated macrophages. II. Competitive inhibition of macrophage-dependent tumor cell killing by mitogen-induced, nonmalignant lymphoblasts.
    Hamilton TA; Fishman M
    Cell Immunol; 1982 Mar; 68(1):155-64. PubMed ID: 7083337
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterologous antiserum to a subpopulation of thymocytes and lymphomas in rats.
    Moriuchi T; Kasai M; Kobayashi H
    Gan; 1979 Dec; 70(6):825-8. PubMed ID: 317055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of T-Cell-mediated lysis. XIII. Lectin-dependent T-cell-mediated cytotoxicity is supported by con A-coupled sepharose beads.
    Ballas ZK; Green WR; Henney CS
    Cell Immunol; 1981 Apr; 59(2):411-8. PubMed ID: 6974603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.